Webb10 feb. 2024 · SCYNEXIS Announces Positive Results from Its Pivotal Phase 3 CANDLE Study of Oral Ibrexafungerp for Prevention of Recurrent Vaginal Yeast Infections, Clearing the Way for Regulatory Submission... WebbH.C. Wainwright & Co. is acting as sole book-running manager for the offering. The warrants will have an exercise price of $1.10 per share and exercise period commencing immediately upon issuance and an expiration date of the earlier of (i) such date that is six months after SCYNEXIS publicly announces the approval from the U.S. Food and Drug …
SCYNEXIS (SCYX) Analysts Prediction, Stock Forecast & Price …
http://ir.scynexis.com/news/detail/197/scynexis-announces-pricing-of-35-million-public-offering-of-common-stock-and-warrants Webb22 apr. 2024 · JERSEY CITY, N.J., April 22, 2024 -- SCYNEXIS, Inc. today announced the pricing of its underwritten public offering of common stock, pre-funded warrants and … how old do you have to be to pull a pint
SCYNEXIS Announces Pricing of $85 Million Public Offering of …
WebbFör 1 dag sedan · Taiwan's Semiconductor Success Is Fueling a Surge in Home Prices. Government. New York State Budget Talks in ... SCYNEXIS to Present Ibrexafungerp … Webb11 apr. 2024 · SCYNEXIS, Inc. Announces Submission of New Drug Application to the U.S. Food and Drug Administration for Oral Ibrexafungerp for the Treatment of Vaginal Yeast … WebbJERSEY CITY, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the pricing of its underwritten public offering of common stock, pre … how old do you have to be to play wobbledogs